Journey Medical Corporation
DERM
$7.42
$0.020.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.18% | -8.73% | -7.59% | -4.24% | -4.37% |
| Total Other Revenue | -94.81% | -94.86% | -94.88% | -100.00% | 5,008.75% |
| Total Revenue | -27.40% | -29.69% | -29.11% | -27.69% | 26.38% |
| Cost of Revenue | -15.46% | -19.63% | -15.91% | -32.09% | -30.01% |
| Gross Profit | -31.65% | -33.62% | -34.47% | -25.26% | 77.26% |
| SG&A Expenses | 17.95% | 8.49% | -8.44% | -16.79% | -32.31% |
| Depreciation & Amortization | 2.93% | 15.76% | 34.11% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.28% | -20.52% | -10.63% | -12.60% | -20.49% |
| Operating Income | -422.98% | -1,377.45% | -1,378.22% | -164.11% | 106.33% |
| Income Before Tax | -909.87% | -109.29% | -302.29% | -48.73% | 102.71% |
| Income Tax Expenses | -45.25% | -72.40% | -72.40% | 16.67% | 860.87% |
| Earnings from Continuing Operations | -1,136.54% | -99.64% | -280.79% | -48.45% | 102.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,136.54% | -99.64% | -280.79% | -48.45% | 102.15% |
| EBIT | -422.98% | -1,377.45% | -1,378.22% | -164.11% | 106.33% |
| EBITDA | -154.55% | -179.84% | -311.97% | -458.55% | 118.45% |
| EPS Basic | -486.55% | -100.61% | -213.31% | -28.41% | 104.55% |
| Normalized Basic EPS | -489.60% | -4,616.95% | -1,479.62% | -80.04% | 105.53% |
| EPS Diluted | -2,419.75% | -28.39% | -112.33% | -12.19% | 99.29% |
| Normalized Diluted EPS | -24,763.64% | -260.49% | -382.96% | -48.73% | 99.91% |
| Average Basic Shares Outstanding | 14.17% | 12.80% | 11.90% | 9.76% | 8.01% |
| Average Diluted Shares Outstanding | 10.41% | 8.99% | 8.02% | 5.91% | 11.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |